Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1251.2000 -6.70 (-0.53%)
NSE Oct 22, 2026 10:05 AM
Volume: 7,999
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
1251.20
-0.53%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences Ltd. is trading above its 200 day SMA of 1108.3
More from Alivus Life Sciences Ltd.
Recommended
Market opens lower, Bharat Electronics secures orders worth Rs 1,011 crore
Trendlyne Marketwatch | 22 Oct 2026, 10:07AM
Five stocks to buy from analysts this week - October 21, 2026
The Baseline | 21 Oct 2026, 06:02PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021